Heron Therapeutics, Inc.

HRTXNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
0.50 USD
↘ 0.01 (1.15%)AT CLOSE (11:59 AM EDT)
0.50
↘ 0.00 (0.80%)
POST MARKET (AS OF 07:35 PM EDT)
Post Market
AS OF 07:35 PM EDT
0.50
↘ 0.00 (0.80%)
🔴Market: CLOSED

Heron Therapeutics, Inc. (HRTX) trades at $0.50 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Strong Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, HRTX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 6, 2026.

Open?$0.48
High?$0.52
Low?$0.48
Prev. Close?$0.50
Volume?1.7M
Avg. Volume?2.5M
VWAP?$0.50
Rel. Volume?0.68x
Bid / Ask
Bid?$0.43 × 100
Ask?$0.61 × 100
Spread?$0.18
Midpoint?$0.52
Valuation & Ratios
Market Cap?94.6M
Shares Out?189.3M
Float?148.8M
Float %?78.6%
P/E Ratio?N/A
P/B Ratio?10.36
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
128
Market Cap
96.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.herontx.com
Listed
1987-08-27
Address
4242 CAMPUS POINT COURT, SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 251-4400
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
5
Short Sent.?
25
Piotroski F-Score?3/9Weak
Altman Z-Score?-9.69Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?28.66%Squeeze Risk
Short Interest?42.6M
Days to Cover?13.4
Free Float148.8M
Avg Daily Volume3.2M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.53Strong
Quick Ratio?1.51Adequate
Cash Ratio?0.29Low
Debt/Equity?15.50High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
18
10.36HIGH▾
P/S?
Peers
100
S&P
93
0.63CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-25.7CHEAP▾
EV/Sales?
Peers
100
S&P
86
1.39CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-338.6%WEAK▾
ROA?
S&P
3
-12.6%WEAK▾
Cash Flow & Enterprise
FCF?$-20860000
Enterprise Value?$210.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist